炎症性肠病的基因拼图
The genetic jigsaw of inflammatory bowel disease.
作者信息
Watts D A, Satsangi J
机构信息
Gastrointestinal Unit, The University of Edinburgh, Western General Hospital, Edinburgh, UK.
出版信息
Gut. 2002 May;50 Suppl 3(Suppl 3):III31-6. doi: 10.1136/gut.50.suppl_3.iii31.
Abstract
Following a prolonged period of relative inertia, real progress has been made in the past few years in understanding the pathogenesis of the chronic inflammatory bowel diseases, Crohn's disease and ulcerative colitis. Clinical experience, epidemiological studies, and molecular genetics have provided strong evidence that both genetic and environmental factors are important in disease pathogenesis, and gene-environmental interaction determines disease susceptibility and behaviour.
摘要
在经历了一段相对停滞的漫长时期后，过去几年里在理解慢性炎症性肠病（克罗恩病和溃疡性结肠炎）的发病机制方面取得了实际进展。临床经验、流行病学研究和分子遗传学已提供有力证据，表明遗传因素和环境因素在疾病发病机制中都很重要，且基因-环境相互作用决定疾病易感性和表现。
相似文献
1
The genetic jigsaw of inflammatory bowel disease.炎症性肠病的基因拼图
Gut. 2002 May;50 Suppl 3(Suppl 3):III31-6. doi: 10.1136/gut.50.suppl_3.iii31.
2
Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab.炎症性肠病中肿瘤坏死因子-α受体1和2的多态性及其与英夫利昔单抗反应的关联。
Aliment Pharmacol Ther. 2004 Aug 1;20(3):303-10. doi: 10.1111/j.1365-2036.2004.01946.x.
3
[Polymorphism of the microsatellites and tumor necrosis factor genes in chronic inflammatory bowel diseases].[慢性炎症性肠病中微卫星和肿瘤坏死因子基因的多态性]
Gastroenterol Clin Biol. 1997;21(8-9):555-61.
4
Genetics of inflammatory bowel disease.炎症性肠病的遗传学
Clin Sci (Lond). 1998 May;94(5):473-8. doi: 10.1042/cs0940473.
5
Genetics of inflammatory bowel disease: from bench to bedside?炎症性肠病的遗传学：从实验室到临床？
Acta Odontol Scand. 2001 Jun;59(3):187-92. doi: 10.1080/000163501750266800.
6
Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.炎症性肠病免疫生物治疗的机制和疗效。
Int Rev Immunol. 2010;29(1):4-37. doi: 10.3109/08830180903437212.
7
Genetics of inflammatory bowel disease: progress and prospects.炎症性肠病的遗传学：进展与展望
Hum Mol Genet. 2004 Apr 1;13 Spec No 1:R161-8. doi: 10.1093/hmg/ddh079. Epub 2004 Feb 5.
8
Infliximab Biosimilar (Remsima™) in Therapy of Inflammatory Bowel Diseases Patients: Experience from One Tertiary Inflammatory Bowel Diseases Centre.英夫利昔单抗生物类似药（Remsima™）治疗炎症性肠病患者：来自一家三级炎症性肠病中心的经验
Dig Dis. 2017;35(1-2):91-100. doi: 10.1159/000453343. Epub 2017 Feb 1.
9
[Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].[炎症性肠病（IBD）——病因、发病机制、诊断及治疗的批判性讨论]
Radiologe. 2003 Jan;43(1):1-8. doi: 10.1007/s00117-002-0844-9.
10
IBD5 polymorphisms in inflammatory bowel disease: association with response to infliximab.炎症性肠病中的IBD5基因多态性：与英夫利昔单抗反应的关联
World J Gastroenterol. 2005 Feb 28;11(8):1187-92. doi: 10.3748/wjg.v11.i8.1187.
引用本文的文献
1
The Prevalence of Migraine in Inflammatory Bowel Disease, a Systematic Review and Meta-Analysis.炎症性肠病中偏头痛的患病率：一项系统评价和荟萃分析
Int J Prev Med. 2023 May 27;14:66. doi: 10.4103/ijpvm.ijpvm_413_21. eCollection 2023.
2
Mitochondrial Control in Inflammatory Gastrointestinal Diseases.线粒体在炎症性胃肠病中的调控作用。
Int J Mol Sci. 2022 Nov 28;23(23):14890. doi: 10.3390/ijms232314890.
3
Psoriasis and inflammatory bowel disease: links and risks.银屑病与炎症性肠病：关联与风险
Psoriasis (Auckl). 2016 Jul 20;6:73-92. doi: 10.2147/PTT.S85194. eCollection 2016.
4
A Survey on Migraine Prevalence in Patients with Inflammatory Bowel Disease - A Single Centre Experience.炎症性肠病患者偏头痛患病率的调查——单中心经验
Middle East J Dig Dis. 2016 Oct;8(4):282-288. doi: 10.15171/mejdd.2016.37.
5
Structural brain lesions in inflammatory bowel disease.炎症性肠病中的脑部结构病变。
World J Gastrointest Pathophysiol. 2015 Nov 15;6(4):124-30. doi: 10.4291/wjgp.v6.i4.124.
6
Role of Salmonella enterica exposure in Chilean Crohn's disease patients.沙门氏菌感染在智利克罗恩病患者中的作用。
World J Gastroenterol. 2013 Sep 21;19(35):5855-62. doi: 10.3748/wjg.v19.i35.5855.
7
Correlations between psoriasis and inflammatory bowel diseases.银屑病与炎症性肠病的相关性。
Biomed Res Int. 2013;2013:983902. doi: 10.1155/2013/983902. Epub 2013 Jul 21.
8
The complexity and challenges of genetic counseling and testing for inflammatory bowel disease.炎症性肠病的遗传咨询与检测的复杂性和挑战。
J Genet Couns. 2006 Dec;15(6):465-76. doi: 10.1007/s10897-006-9057-0.
9
Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease.前列腺素合成酶2/环氧化酶2的单倍型与炎症性肠病易感性有关。
World J Gastroenterol. 2005 Oct 14;11(38):6003-8. doi: 10.3748/wjg.v11.i38.6003.
10
Consistent across-tissue signatures of differential gene expression in Crohn's disease.克罗恩病中差异基因表达的跨组织一致特征。
Immunogenetics. 2005 Nov;57(10):709-16. doi: 10.1007/s00251-005-0044-7. Epub 2005 Nov 8.
本文引用的文献
1
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.NOD2基因中的一个移码突变与克罗恩病易感性相关。
Nature. 2001 May 31;411(6837):603-6. doi: 10.1038/35079114.
2
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.NOD2富含亮氨酸重复序列变异与克罗恩病易感性的关联
Nature. 2001 May 31;411(6837):599-603. doi: 10.1038/35079107.
3
Review article: the genetics of inflammatory bowel disease.综述文章：炎症性肠病的遗传学
Aliment Pharmacol Ther. 2001 Jun;15(6):731-48. doi: 10.1046/j.1365-2036.2001.00981.x.
4
ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease.抗中性粒细胞胞浆抗体（ANCA）模式和脂阿拉伯甘露聚糖（LTA）单倍型与克罗恩病患者抗TNF抗体治疗临床反应的关系
Gastroenterology. 2001 May;120(6):1347-55. doi: 10.1053/gast.2001.23966.
5
Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease.利用红细胞6-硫鸟嘌呤代谢物水平优化炎症性肠病患者的硫唑嘌呤治疗。
Gut. 2001 May;48(5):642-6. doi: 10.1136/gut.48.5.642.
6
Prospective survey of childhood inflammatory bowel disease in the British Isles.不列颠群岛儿童炎症性肠病的前瞻性调查。
Lancet. 2001 Apr 7;357(9262):1093-4. doi: 10.1016/s0140-6736(00)04309-9.
7
The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy.硫唑嘌呤治疗失败后，6-巯基嘌呤在炎症性肠病患者中的应用。
Aliment Pharmacol Ther. 2000 Dec;14(12):1561-5. doi: 10.1046/j.1365-2036.2000.00872.x.
8
Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL.严重溃疡性结肠炎的易感性与主要组织相容性复合体（MHC）核心基因IKBL的多态性相关。
Gastroenterology. 2000 Dec;119(6):1491-5. doi: 10.1053/gast.2000.20258.
9
The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn disease.IBD2基因座在溃疡性结肠炎和克罗恩病之间表现出连锁异质性。
Am J Hum Genet. 2000 Dec;67(6):1605-10. doi: 10.1086/316905. Epub 2000 Nov 10.
10
Searching for genetic determinants in the new millennium.在新千年中寻找基因决定因素。
Nature. 2000 Jun 15;405(6788):847-56. doi: 10.1038/35015718.
Zotero 插件